Join to View Full Profile
3855 Mc 0843 San Diego Health Sys# UcLa Jolla, CA 92093
Phone+1 858-822-6040
Fax+1 858-822-1533
Dr. Hattangadi-Gluth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2008 - 2012
MedStart Georgetown University HospitalInternship, Transitional Year, 2007 - 2008
Harvard Medical SchoolClass of 2007
Certifications & Licensure
CA State Medical License 2012 - 2026
MA State Medical License 2009 - 2014
VA State Medical License 2007 - 2008
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- NCCN CNS Tumor Guidelines Update for 2024.Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, Jana Portnow
Neuro-Oncology. 2025-03-07 - Trajectories of Cortical Atrophy Differ According to Cognitive Phenotype in Adults With Primary Brain Tumors.Jiwandeep S Kohli, Anny Reyes, Austin Hopper, Alena Stasenko, Natalia Menendez
International Journal of Radiation Oncology, Biology, Physics. 2025-02-12 - 2 citationsCognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy.Anny Reyes, Alena Stasenko, Austin Hopper, Jiwandeep S Kohli, Jonathan L Helm
Neuro-Oncology. 2025-02-10
Press Mentions
Proton CSI: New Standard of Care for Leptomeningeal Metastases?October 14th, 2024- Study: Cancer Patients Increasingly Turning to CannabisMay 18th, 2019
Study Finds Patients with Cancer More Likely to Use MarijuanaApril 25th, 2019- Join now to see all
Grant Support
- Mechanisms of Radiation-Induced Neurocognitive Decline (MIND): Longitudinal Study of Imaging Biomarkers and Risk and Resilience Factors Underlying Cognitive Phenotypes in Patients with GliomaUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
